增加PRIM1表达和人类泌尿腺癌的不良预后之间的关联
Ban A Al-Hassany1, Israa M Al-Sudani1
1Department of Pathology, College of Medicine, Ibn Sina University for Medical and Pharmaceutical Sciences Baghdad, Iraq.
尿路癌中DNA原酶子单元1 (PRIM1) 表达率升高与晚期疾病和较差的存活率相关. 这一发现表明PRIM1是膀癌的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 泌尿腺癌是一种常见的恶性瘤,具有显著的全球影响.
- DNA原酶子单元1 (PRIM1) 涉及各种癌症,但其在尿癌中的作用尚未研究.
研究的目的:
- 为了研究PRIM1在尿路癌中的表达.
- 分析PRIM1与关键调节基因 (RB1,ANKRD30A,FLNA,TECPR2) 的分子相互作用.
- 确定PRIM1对瘤行为和患者预后的影响.
主要方法:
- 对公开可用的数据集 (TCGA/GEO) 的回顾性分析.
- 包括169个尿癌样本和21个正常的膀组织.
- 评估PRIM1mRNA和蛋白质水平,以及与突变和整体存活率的相关性.
主要成果:
- 尿癌组织在mRNA和蛋白质水平上显示出显著的PRIM1过度表达.
- 增加PRIM1表达与晚期疾病和减少患者存活率 (p <0.05) 有关.
- PRIM1上调与RB1,ANKRD30A,FLNA和TECPR2的突变相关,这表明它在DNA复制和瘤发育中的作用.
结论:
- PRIM1是一种潜在的预后生物标志物和尿癌的治疗标.
- 这项研究强调了DNA复制机械和膀癌中的遗传突变之间的相互作用.
- 这些发现可能为新的向疗法和尿癌中的生物标志物发现铺平道路.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
03:32Patient-derived Tumor Xenografting: A Technique to Generate Experimental Mouse Model for Evaluating Urothelial Cell Carcinoma
Published on: April 30, 2023
相关概念视频
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
03:32Patient-derived Tumor Xenografting: A Technique to Generate Experimental Mouse Model for Evaluating Urothelial Cell Carcinoma
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
10:17An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
09:16Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells
15:43Experimental Generation of Carcinoma-Associated Fibroblasts (CAFs) from Human Mammary Fibroblasts
